

Atorvastatin (10mg) + Fenofibrate (160mg)
10 tablets in 1 strip
Cash on delivery available
Atchol-F Tablet combines two active ingredients, fenofibrate and atorvastatin, to provide synergistic benefits in managing lipid levels and protecting cardiovascular health. Fenofibrate belongs to the class of medications known as fibrates, which work by increasing the breakdown and elimination of triglycerides while also raising HDL cholesterol levels. Atorvastatin, a statin medication, inhibits cholesterol synthesis in the liver and lowers LDL cholesterol levels in the bloodstream.
Atchol-F Tablet is indicated for the treatment of dyslipidemia, a condition characterized by abnormal lipid levels in the blood, including elevated LDL cholesterol, triglycerides, and low HDL cholesterol. By addressing these lipid abnormalities, Atchol-F Tablet helps reduce the risk of cardiovascular diseases such as heart attack, stroke, and peripheral artery disease. It is often prescribed for individuals with mixed dyslipidemia or those at high risk of cardiovascular events.
The primary benefit of Atchol-F Tablet lies in its dual action in managing lipid levels and protecting cardiovascular health. Fenofibrate targets triglycerides and HDL cholesterol, while atorvastatin focuses on LDL cholesterol, resulting in a comprehensive improvement in lipid profiles. By optimizing lipid levels, Atchol-F Tablet helps reduce the risk of atherosclerosis and its associated complications, thereby promoting overall cardiovascular well-being.
While Atchol-F Tablet is generally well-tolerated, it may cause side effects in some individuals. Common side effects associated with fenofibrate may include gastrointestinal disturbances, such as nausea or diarrhea, as well as muscle pain or weakness. Atorvastatin, like other statins, may also cause muscle-related side effects and liver abnormalities in rare cases. It is essential to be vigilant for any signs of adverse effects while taking Atchol-F Tablet and promptly report them to a healthcare provider.
Atchol-F Tablet should be taken exactly as prescribed by a healthcare professional. The recommended dosage and frequency may vary depending on individual lipid levels, cardiovascular risk factors, and overall health status. It is typically administered orally, with or without food, once daily. Adherence to the prescribed dosage regimen is crucial to achieve optimal lipid control and cardiovascular protection. Regular monitoring of lipid levels and liver function may be necessary to assess treatment response and detect any potential adverse effects.
Atchol-F Tablet exerts its therapeutic effects through the combined actions of fenofibrate and atorvastatin. Fenofibrate works by activating peroxisome proliferator-activated receptor alpha (PPAR-alpha), which regulates genes involved in lipid metabolism. This leads to increased breakdown and elimination of triglycerides and a rise in HDL cholesterol levels. Atorvastatin inhibits HMG-CoA reductase, reducing cholesterol synthesis in the liver and lowering LDL cholesterol levels in the bloodstream. Together, fenofibrate and atorvastatin in Atchol-F Tablet provide comprehensive lipid management and cardiovascular protection.
In summary, Atchol-F Tablet offers a multifaceted approach to managing dyslipidemia and reducing the risk of cardiovascular diseases. Its combination of fenofibrate and atorvastatin addresses various lipid abnormalities, resulting in improved lipid profiles and enhanced cardiovascular health. However, it is essential to use Atchol-F Tablet as directed and under the supervision of a healthcare professional to maximize its benefits and minimize the risk of adverse effects.
Cash on delivery available